Vivani Medical, Inc. (VANI) Operating Margin
- Operating margin · 12 months: Value (m); Formula and calculation Operating income / revenue. Period ending 2026-06-30..
Operating margin
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Operating margin · 12 months | (m) | Operating income / revenue. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Operating income | -27.36M USD | Operating Income (Loss) |
| Revenue | (m) | |
| Cost of products and services | (m) | Cost of Goods and Services Sold |
| Research and development | 18.11M USD | Research and Development Expense |
| Selling, general and administration | (m) |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Operating income (USD) | Revenue (USD) | Cost of products and services (USD) | Research and development (USD) | Selling, general and administration (USD) | Operating margin |
|---|---|---|---|---|---|---|
| 2026-06-30 | $-27.36M | (m) | (m) | $18.11M | (m) | (m) |
| 2026-03-31 | $-27.82M | (m) | (m) | $18.30M | (m) | (m) |
| 2025-12-31 | $-27.56M | (m) | (m) | $18.13M | (m) | (m) |
| 2025-09-30 | $-27.21M | (m) | (m) | $17.80M | (m) | (m) |
| 2025-06-30 | $-26.79M | (m) | (m) | $17.48M | (m) | (m) |
| 2025-03-31 | $-25.01M | (m) | (m) | $16.24M | (m) | (m) |
| 2024-12-31 | $-24.68M | (m) | (m) | $15.74M | (m) | (m) |
| 2024-09-30 | $-24.43M | (m) | (m) | $16.15M | (m) | (m) |
| 2024-06-30 | $-25.27M | (m) | (m) | $16.39M | (m) | (m) |
| 2024-03-31 | $-26.59M | (m) | (m) | $16.74M | (m) | (m) |
| 2023-12-31 | $-26.96M | (m) | (m) | $16.97M | (m) | (m) |
| 2023-09-30 | $-28.54M | (m) | (m) | $16.69M | (m) | (m) |
| 2023-06-30 | $-26.85M | (m) | (m) | $16.11M | (m) | (m) |
| 2023-03-31 | $-23.93M | (m) | (m) | $15.45M | (m) | (m) |
| 2022-12-31 | $-21.24M | (m) | (m) | $14.17M | (m) | (m) |
| 2022-09-30 | $-12.61M | (m) | (m) | $4.08M | (m) | (m) |
| 2022-06-30 | $-9.14M | (m) | (m) | $2.83M | (m) | (m) |
| 2022-03-31 | $-8.31M | (m) | (m) | $2.68M | (m) | (m) |
| 2021-12-31 | $-8.93M | (m) | $130.00K | $2.37M | (m) | (m) |
| 2021-09-30 | $-8.92M | (m) | (m) | $2.07M | (m) | (m) |
| 2021-06-30 | $-8.02M | (m) | $500.00K | $1.66M | (m) | (m) |
| 2021-03-31 | $-8.84M | (m) | (m) | $1.28M | (m) | (m) |
| 2020-12-31 | $-14.90M | (m) | $500.00K | $4.84M | (m) | (m) |
| 2020-09-30 | $-21.75M | (m) | (m) | $8.63M | (m) | (m) |
| 2020-06-30 | $-27.77M | (m) | (m) | $11.73M | (m) | (m) |
| 2020-03-31 | $-33.09M | (m) | (m) | $14.85M | (m) | (m) |
| 2019-12-31 | $-33.95M | (m) | $2.15M | $13.14M | (m) | (m) |
| 2019-09-30 | $-34.70M | (m) | $3.63M | $11.44M | (m) | (m) |
| 2019-06-30 | $-35.63M | (m) | $5.05M | $10.73M | (m) | (m) |
| 2019-03-31 | $-35.18M | (m) | $4.95M | $9.71M | (m) | (m) |
| 2018-12-31 | $-35.18M | (m) | $4.89M | $10.01M | (m) | (m) |
| 2018-09-30 | $-33.74M | (m) | (m) | $9.84M | (m) | (m) |
| 2018-06-30 | $-31.94M | (m) | (m) | $8.99M | (m) | (m) |
| 2018-03-31 | $-30.82M | (m) | (m) | $8.52M | (m) | (m) |
| 2017-12-31 | $-28.61M | (m) | (m) | $7.89M | (m) | (m) |
| 2017-09-30 | $-31.56M | (m) | (m) | $7.70M | (m) | (m) |
| 2017-06-30 | $-33.31M | (m) | (m) | $7.46M | (m) | (m) |
| 2017-03-31 | $-34.94M | (m) | (m) | $6.43M | (m) | (m) |
| 2016-12-31 | $-33.21M | $4.00M | (m) | $5.35M | (m) | -830.25% |
| 2016-09-30 | $-28.30M | (m) | (m) | $3.81M | (m) | (m) |
| 2016-06-30 | $-24.47M | (m) | (m) | $2.82M | (m) | (m) |
| 2016-03-31 | $-20.05M | $8.95M | (m) | $3.04M | (m) | -224.01% |
| 2015-12-31 | $-20.05M | $8.95M | (m) | $3.04M | (m) | -223.99% |
| 2015-09-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2015-06-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2015-03-31 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2014-12-31 | $-21.23M | $3.40M | (m) | $5.04M | (m) | -624.87% |
| 2014-09-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2014-06-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2014-03-31 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2013-12-31 | $-18.00M | $1.56M | (m) | $3.25M | (m) | -1150.03% |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Neuraxis, INC (NRXS) | United States | $0.097B | |
| Nexalin Technology, Inc. (NXL) | United States | $0.094B | |
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| Streamex Corp. (STEX) | United States | $0.089B | -0.19 |
| Outset Medical, Inc. (OM) | United States | $0.059B | -1.09 |
| PRECISION OPTICS CORPORATION, INC. (POCI) | United States | $0.052B | |
| EDAP TMS SA (FOCL) | $0.171B | ||
| QT IMAGING HOLDINGS, INC. (QTI) | United States | $0.037B | |
| IRIDEX CORP (IRIX) | United States | $0.011B |